Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6156472 | 0.80 | KDM4E (0.57) | KDM4EGLAMAPTRECQLRAB9A | |
| SCHEMBL29390623 | 0.79 | KAT2B (0.66) | KMT2AMAPTRAB9ATSHRTDP1 | |
| SCHEMBL110446 | 0.79 | KAT2B (0.66) | KMT2AMAPTRAB9ATSHRTDP1 | |
| Hydrochloric Acid SCHEMBL27635117 | 0.77 | KAT2B (0.67) | KMT2AMAPTRAB9ATSHRTDP1 | |
| SCHEMBL4619073 | 0.76 | KAT2B (0.51) | KDM4EGLAKMT2AMAPTRECQL | |
| SCHEMBL197715 | 0.76 | KDM4E (0.44) | KDM4EGLAKMT2AMAPTRECQL | |
| SCHEMBL4257954 | 0.76 | CHEK1 (0.48) | KDM4EKMT2AMAPTRAB9AALDH1A1 | |
| Hydrochloric Acid SCHEMBL5063788 | 0.75 | KAT2B (0.54) | KDM4EGLAKMT2AMAPTRECQL | |
| Diethanolamine SCHEMBL198856 | 0.75 | KAT2B (0.60) | KMT2AMAPTRAB9ATSHRTDP1 | |
| SCHEMBL7882836 | 0.74 | MAPT (0.41) | KDM4EGLAKMT2AMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7341604-B2 | Highly affine cosmetic agent | WELLA AG (DE) | 2008-03-11 | — | — | US | disclosed |
| US-20060174423-A1 | Highly affine cosmetic agent | Wella GmbH (DE) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060174423-A1 | Highly affine cosmetic agent | TYR, ENO1, CUTA | KDM4E 2808/4885GLA 53/4885KMT2A 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.